Holen Sie sich die Stockscreener-App
175.64
2.87%
4.90
Handel nachbörslich:
175.64
Finanzdaten der Krystal Biotech Inc-Aktie (KRYS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
7.37%
45.25
|
42.14 | 8.556 | - | - |
Operating Expenses
|
33.15%
51.93
|
39.01 | 34.55 | 38.05 | 48.82 |
| Benefits Costs and Expenses |
100.00%
-
|
37.80 | - | - | - |
| Costs And Expenses |
162.11%
51.93
|
-83.62 | 34.55 | - | - |
| Operating Income/Loss |
313.00%
-6.684
|
3.138 | -25.99 | -38.05 | -48.82 |
| Income/Loss From Continuing Operations Before Tax |
942.39%
45.25
|
4.341 | 8.556 | -33.21 | -45.30 |
| Income/Loss From Continuing Operations After Tax |
89.28%
0.932
|
8.692 | 80.75 | -33.21 | -45.30 |
|
Net Income/Loss
|
89.28%
0.932
|
8.692 | 80.75 | -33.21 | -45.30 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
8,176%
28.30
|
0.3419 | 28.04 | 26.66 | 25.71 |
| Diluted Average Shares |
7,875%
29.29
|
0.3673 | 28.89 | 26.66 | 25.71 |
| Basic Earnings Per Share |
90.63%
0.03
|
0.32 | 2.88 | -1.25 | -1.76 |
| Diluted Earnings Per Share |
90.32%
0.03
|
0.31 | 2.79 | -1.25 | -1.76 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):